BAYER AG NA O.N.
Commented by Fabian Lorenz on December 14th, 2021 | 12:40 CET
BioNTech, Bayer, Ayurcann: From vaccination records to cannabis
The COVID-19 pandemic is dominating the headlines. There is no end in sight to the pandemic. The shares of BioNTech are benefiting from this. The Mainz-based Company has developed the most successful vaccine to date. The blockbuster is likely to remain in demand and generate billions in revenue for BioNTech. Thus, Berenberg sees a price target of USD 400. Health Minister Karl Lauterbach referred to a necessary vaccination rate of over 90% in the ARD program "Anne Will". BioNTech is currently expanding its production capacity. Just like Ayurcann. Because the legalization of cannabis opens the door to a billion-dollar market for the Canadian Company. Bayer also made headlines yesterday - the US Supreme Court is taking a closer look at the glyphosate dispute. That is new food for the gamblers. They have the Bayer share firmly in their grip.
ReadCommented by Stefan Feulner on December 10th, 2021 | 13:54 CET
Bayer, Almonty Industries, JinkoSolar - Still considerable room for improvement
Inflation is growing relentlessly. In November, Germany's barometer for price increases climbed to 5.2%; a level last reached 29 years ago. Rising energy prices and exploding commodity prices are found to be the culprits here. Given the energy turnaround, the materials required for this, such as lithium, copper and cobalt, are in fact close to their highs. However, tungsten, which will be essential for electromobility in the future, still has some catching-up potential.
ReadCommented by Stefan Feulner on December 2nd, 2021 | 11:02 CET
Bayer, Ayurcann, JinkoSolar - Excellent prospects
"Release the hemp!" cult presenter Stefan Raab called for the legalization of cannabis years ago in a song he produced himself. But not Jamaica, but the traffic light coalition with SPD, FDP and the Greens caused jubilation in the various communities. The release of the drug opens up great opportunities for young companies as well as investors. In contrast to Germany, other countries have already made more progress. Currently, the cannabis sector is in correction mode on the stock market, but the long-term prospects are excellent.
ReadCommented by Armin Schulz on November 29th, 2021 | 11:36 CET
MorphoSys, Osino Resources, Bayer - Profits through takeovers
The world's most expensive takeover occurred in Germany when the Vodafone Group acquired the Mannesmann Group for EUR 190 billion in 2000. Initially, Vodafone offered only EUR 100 billion. When a company wants to take over a listed company, it must make a public offer to shareholders. At this point, the buying party is usually already the major shareholder in the takeover target. As a rule, these offers are significantly higher than the current share price in order to make the deal palatable to the shareholders. Payment is made in cash, in shares of the acquiring Company or with a mix of both. Today, we look at three companies that are the subject of takeover rumors.
ReadCommented by Fabian Lorenz on November 11th, 2021 | 13:02 CET
Bayer, TUI, Sativa Wellness: Figures move share prices
The reporting season is drawing to a close. Overall, most companies have been convincing, and the stock markets have been very friendly in recent weeks. Bayer published positive quarterly figures, raised its forecast for the full year and thus convinced the analysts from DZ Bank. Sativa Wellness benefits from the boom around cannabis and CBD. The still-new boom is growing strongly and is already in the black. At TUI, the operating figures play less of a role. The development of the Corona figures and, thus, possible travel restrictions in the coming winter are more critical. Read more about all three shares here.
ReadCommented by Stefan Feulner on November 1st, 2021 | 13:20 CET
Bayer, MAS Gold, Salzgitter - Positive turnaround
At chemical and pharmaceutical giant Bayer, the mood continues to brighten following the important decision of the European Patent Office. Also, the number season, which has been running for weeks, gives the markets an additional boost with solid figures and forecast increases. New highs in the most critical global stock indices are the result. On the other hand, the high inflation rates are a cause for concern, although they continue to be underestimated by the monetary watchdogs. The still weak precious metals markets could therefore experience a boom in the coming months.
ReadCommented by Armin Schulz on October 20th, 2021 | 11:04 CEST
Bayer, Sativa Wellness Group, MorphoSys - Can the pharmaceutical industry benefit from the new German government?
The federal election is over, and the pharmaceutical industry has to adjust to the new political constellation. The industry is facing change. Digitization is an important topic. To not lose even more researchers to foreign countries, approval processes must be accelerated and bureaucracy reduced. If we always acted as decisively as we did during the pandemic, much more could be achieved. The new federal government is flirting with the legalization of cannabis. If this were to happen, the market would probably be huge. The next four years promise to be exciting.
ReadCommented by Nico Popp on October 18th, 2021 | 10:44 CEST
BioNTech, Cardiol Therapeutics, Bayer: Where triple-digit returns beckon
The pandemic is drawing to a close. Vaccination rates are high, and a new wave is - fortunately - not picking up speed. But in this environment, what is happening to many highly acclaimed pandemic stocks? Are vaccine manufacturers still interesting at the moment? We look at how the industry is faring and where opportunities can still be found.
ReadCommented by Armin Schulz on October 15th, 2021 | 12:19 CEST
Bayer, Water Ways Technologies, K+S - Will there be enough food for everyone in the future?
Humanity is growing and growing. In a few years, 10 billion people will populate the earth. The question then arises as to whether there will be enough food available in the future. One of the difficulties is climate change. If it gets hotter and hotter, less will grow, and if agricultural land becomes smaller, less food can be produced. To meet this challenge, yields on arable land must be increased. Fertilizers can help. Another critical factor will be water. Water is already scarce in some parts of the world, and drinking water is far from accessible to everyone everywhere. Today we analyze three companies that could play an important role in the future of food supply.
ReadCommented by Stefan Feulner on October 11th, 2021 | 10:26 CEST
Deutsche Post, Memiontec, Bayer - Here is where the action is
After heavy losses in recent weeks - the DAX losing more than 1,200 points at its peak and briefly slipping below the 15,000-point mark - the mood is brightening again. The German benchmark index, now made up of 40 members, is back on track for a year-end rally despite concerns about stagflation. The 16,000 peak beckons once again. Individual stocks are likely to outperform in the final weeks of the stock market year based on the recently reported fundamental data.
Read